Navigation Links
Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum
Date:4/10/2008

SANTA CLARA, Calif., April 10 /PRNewswire/ -- Dedicating this year's Venture Forum to the life sciences industry, Larta Institute and Burrill & Company have announced a partnership in developing and producing the 2008 Life Sciences Venture Forum, which will showcase the most promising and innovative seed and early-stage life sciences companies from the U.S. and around the globe. The 2008 Life Sciences Venture Forum will take place on May 30, 2008, at the Santa Clara Convention Center and will provide venture capitalists, angel investors and industry representatives the opportunity to get a first look at companies that are not seen on the regular conference circuit and cannot be accessed via traditional pipelines.

"This partnership unites the best of the best," said Rohit Shukla, CEO of Larta Institute. "It extends the reach, brand and credibility of Burrill & Company to the world of early-stage innovations and Larta Institute's own focus and access to that pool of talent," he added. "With this partnership, the Venture Forum grows several notches."

G. Steven Burrill, CEO of Burrill & Company, said, "Different areas of discovery are converging in the life sciences. There is no more exciting a time for emerging innovations to fill large holes in the realization of these trends." He added that "the 2008 Life Sciences Venture Forum promises to be an important platform for demonstration and feedback of these innovations, and we are excited to be a part of it."

Now 14 years strong, the Venture Forum is the largest and longest-running showcase of early stage innovation and entrepreneurship. It is the must-attend event for those seeking access to untapped early-stage deal flow from around the world.

Larta Institute's Commercialization Assistance Practice is rooted in a set of year-round programs that uncover, coach and train innovators funded by institutions such as the National Institutes of Health, the US Department of Agriculture and a network of over 25 universities. Larta's practice extends to all corners of the globe, uncovering market-ready innovations spinning out of research institutes and leading R&D centers. Through its dedicated Life Science Practice, Larta Institute works with more than 100 emerging companies every year.

Burrill & Company works exclusively with life sciences companies; through its industry expertise, Burrill & Company gives pioneering companies the tools they need to start strong and maintain growth via venture capital funds, merchant banking and the formation of business development partnerships. Unsurpassed in industry networking, Burrill & Company provides invaluable resources, strategies and years of dedicated experience to promising life sciences companies.

Burrill & Company's specific expertise and breadth of knowledge in life sciences constitute a strong complement to Larta Institute's commercialization assistance practice and industry network. The resources and commitment of both partner organizations will be leveraged to advance the visibility and success of all presenting and exhibiting entrepreneurs at the 2008 Life Sciences Venture Forum.

2008 Life Sciences Venture Forum (May 30, 2008 - Santa Clara Convention Center)

Attendee Registration Registration for the event is $995. Register early to receive a 40% discount. Go to http://www.theventureforum.com/registration.asp.

Credentialed Media: To register for a press pass, please contact Avi Kulokas at akulokas@larta.org or 213-538-1451.

Sponsorship Opportunities For information on sponsorship opportunities contact Carlos Gutierrez at cgutierrez@larta.org or 213-538-1453.

For more information about Larta Institute, please visit http://www.larta.org.

For more information about Burrill & Company, please visit http://www.burrillandcompany.com.

Contact:

Constanza Pachon

Tel.: 213/538-1451

Email: cpachon@larta.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Larta Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Loma Linda University Partners With Larta Institute for Technology Marketing Program
2. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
3. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
4. Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
5. Piedmont Heart Institute Welcomes Cardiology of Georgia
6. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
7. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
8. Aida Acquires High-Level Research Institute in China
9. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
10. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
11. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):